期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Sarcopenia in pancreatic cancer–effects on surgical outcomes and chemotherapy 被引量:6
1
作者 miu yee chan Kenneth Siu Ho Chok 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2019年第7期527-537,共11页
Sarcopenia is found in up to 65% of pancreatic cancer patients. The definition and diagnostic methods for sarcopenia have changed over the years, and the measurement of skeletal muscle mass with cross-sectional imagin... Sarcopenia is found in up to 65% of pancreatic cancer patients. The definition and diagnostic methods for sarcopenia have changed over the years, and the measurement of skeletal muscle mass with cross-sectional imaging has become the most popular way of assessment, although the parameters measured vary among different studies. It is still debatable that there is an association between sarcopenia and postoperative pancreatic fistula, but most studies showed a higher risk in patients with sarcopenic obesity. Long-term survival is worse in sarcopenic patients, as shown by meta-analysis. Sarcopenia is also associated with decreased survival and higher toxicity in patients receiving chemotherapy, and chemotherapy also tends to potentiate sarcopenia. Treatment for sarcopenia still remains an area for research, although oral supplements, nutritional modifications and exercise training have been shown to improve sarcopenia. 展开更多
关键词 SARCOPENIA PANCREATIC cancer Clinical OUTCOMES Surgical OUTCOMES CHEMOTHERAPY RADIOTHERAPY
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部